Ibrahim Rudhani, Naim Morina, Premtim Rashiti
University of Prishtina "Hasan Prishtina", Prishtina, Republic of Kosovo.
Clinic of Nephrology and Haemodialysis UCCK Kosovo Hospital Circle N.n, 10000, Pristina, Republic of Kosovo.
Ann Med Surg (Lond). 2022 Jun 11;79:103913. doi: 10.1016/j.amsu.2022.103913. eCollection 2022 Jul.
this study aims to evaluate the pain scale during Arteriovenous fistula (AVF) puncture in patients undergoing regular haemodialysis sessions with and without Lidocaine gel 2%.
The study is Cross-Sectional, conducted at the University Clinical Centre of Kosovo - Clinic of Nephrology and Haemodialysis in Pristina, Regional Haemodialysis Centre in Prizren, Regional Haemodialysis Centre in Gjilan and Regional Haemodialysis Centre in Mitrovica, all in Kosovo. In this research, 616 patients were surveyed during AVF puncture and the other group of 232 patients in whom 2% Lidocaine gel was applied before puncture at the fistula puncture site.
In the above mentioned centres, the total number of patients who are on dialysis through AVF is 632, of which 324 men and 308 women. 560 patients had created AVF on the left arm and 72 patients on the right arm. In our research, 616 patients were surveyed, of which 312 men and 304 women. The most affected age group was between 60 and 69. The pain scale reported during AVF punctuation was moderate in 304 (49%) patients, severe in 176 patients (29%) and mild in 136 (22%) patients. After the applying of Lidocaine gel 2%, the puncture of AVF was performed, so from the total number of 232 participants, 64 (28%) of them reported moderate pain and 168 (72%) of research participants reported mild pain during puncture of AVF. In order to compare results from both groups, we have chosen a random sample from the first group during AVF punctuation without Lidocaine gel 2% (234 in total from 616 patients) and compared the result with the second group during AVF puncture with Lidocaine gel 2% (232 in total).
The average pain scale during AVF puncture without Lidocaine gel 2% was 5.04 while the average pain scale after applied Lidocaine gel 2% was 2.61.
本研究旨在评估在定期进行血液透析的患者中，使用和不使用2%利多卡因凝胶时动静脉内瘘（AVF）穿刺过程中的疼痛程度。
本研究为横断面研究，在科索沃大学临床中心——普里什蒂纳的肾脏病与血液透析诊所、普里兹伦的区域血液透析中心、贾科维察的区域血液透析中心以及米特罗维察的区域血液透析中心进行，所有这些中心均位于科索沃。在本研究中，616例患者在AVF穿刺时接受了调查，另一组232例患者在瘘管穿刺部位穿刺前应用了2%利多卡因凝胶。
在上述中心，通过AVF进行透析的患者总数为632例，其中男性324例，女性308例。560例患者在左臂建立了AVF，72例患者在右臂建立了AVF。在我们的研究中，616例患者接受了调查，其中男性312例，女性304例。受影响最大的年龄组在60至69岁之间。在AVF穿刺期间报告的疼痛程度为：304例（49%）患者为中度，176例（29%）患者为重度，136例（22%）患者为轻度。在应用2%利多卡因凝胶后进行了AVF穿刺，因此在232名参与者总数中，64例（28%）报告穿刺时为中度疼痛，168例（72%）研究参与者报告穿刺时为轻度疼痛。为了比较两组的结果我们从第一组中随机抽取了在AVF穿刺时未使用2%利多卡因凝胶的样本（616例患者中总共234例），并将结果与第二组在AVF穿刺时使用2%利多卡因凝胶的结果进行比较（总共232例）。
在不使用2%利多卡因凝胶的情况下，AVF穿刺时的平均疼痛程度为5.04，而在应用2%利多卡因凝胶后的平均疼痛程度为2.61。
